Видео ютуба по тегу Nmosd Clinical Trials

Emerging Tolerization Technologies & Clinical Trials | NMOSD Grand Rounds
Emerging Tolerization Technologies & Clinical Trials | NMOSD Grand Rounds
#aquaporin#AQ4#Serum#NMOSD#POSTREMAsyndrome#nueromyelitis#IIFA#Cellbasedassay#iimmunology#CSF#molbio
#aquaporin#AQ4#Serum#NMOSD#POSTREMAsyndrome#nueromyelitis#IIFA#Cellbasedassay#iimmunology#CSF#molbio
Assessing treatment efficacy in MS and NMOSD: moving beyond relapse rates
Assessing treatment efficacy in MS and NMOSD: moving beyond relapse rates
Understanding NMOSD The Rare Cousin of MS
Understanding NMOSD The Rare Cousin of MS
#124: Multiple Sclerosis Clinical Trials – Discover the Benefits, Ease the Worries
#124: Multiple Sclerosis Clinical Trials – Discover the Benefits, Ease the Worries
New Disease Modifying Therapies for MS, Upcoming Clinical Trials & Understanding NMOSD
New Disease Modifying Therapies for MS, Upcoming Clinical Trials & Understanding NMOSD
Participating in Clinical Trials: How Patients Can Make a Difference
Participating in Clinical Trials: How Patients Can Make a Difference
NMOSD in sub-Saharan Africa
NMOSD in sub-Saharan Africa
2024 RNDS | NMOSD and MOGAD Clinical Trials
2024 RNDS | NMOSD and MOGAD Clinical Trials
2024 RNDS | Advances in Immunotherapies and Tolerance
2024 RNDS | Advances in Immunotherapies and Tolerance
2024 RNDS | Neuromyelitis Optica Spectrum Disorder (NMOSD)
2024 RNDS | Neuromyelitis Optica Spectrum Disorder (NMOSD)
102. Meteoroid and cosMOG Clinical Trials for MOGAD Treatments
102. Meteoroid and cosMOG Clinical Trials for MOGAD Treatments
Ремиелинизация при рассеянном склерозе: клинические испытания ремиелинизации и многое другое! — У...
Ремиелинизация при рассеянном склерозе: клинические испытания ремиелинизации и многое другое! — У...
Participating in Clinical Trials: How Patients Can Make a Difference
Participating in Clinical Trials: How Patients Can Make a Difference
2024 NMOSD Together | Community Q&A
2024 NMOSD Together | Community Q&A
MOG Minute: Clinical Trials in MOGAD
MOG Minute: Clinical Trials in MOGAD
New App Can Better Monitor Patients With NMOSD
New App Can Better Monitor Patients With NMOSD
An overview of the current treatment options for NMOSD from ACTRIMS 2024
An overview of the current treatment options for NMOSD from ACTRIMS 2024
Participating in Clinical Trials: How Patients Can Make a Difference
Participating in Clinical Trials: How Patients Can Make a Difference
Addressing Diversity Gaps in Neuromyelitis Optica Spectrum Disorder Research
Addressing Diversity Gaps in Neuromyelitis Optica Spectrum Disorder Research
Michael on Meteoroid for MOGAD: Understanding the Satralizumab Clinical Trial
Michael on Meteoroid for MOGAD: Understanding the Satralizumab Clinical Trial
MRI data from N-MOmentum: impact of inebilizumab on subclinical spinal lesions in NMOSD
MRI data from N-MOmentum: impact of inebilizumab on subclinical spinal lesions in NMOSD
2023 RNDS | Clinical trials in MOGAD, NMOSD, and more
2023 RNDS | Clinical trials in MOGAD, NMOSD, and more
Prospects and challenges in NMOSD treatment
Prospects and challenges in NMOSD treatment
Participating in Clinical Trials: How Patients Can Make a Difference
Participating in Clinical Trials: How Patients Can Make a Difference